SHARLOTTE SARGENT: Open Payments
NPI 1821538745 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: SPRAVATO, CAPLYTA, INGREZZA, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
